Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 251.37B | 226.71B | 228.06B | 207.97B | 209.12B |
Gross Profit | 116.54B | 104.78B | 106.80B | 101.09B | 87.75B |
EBITDA | 74.55B | 66.11B | 63.26B | 61.18B | 52.95B |
Net Income | 43.04B | 38.03B | 41.09B | 38.78B | 33.47B |
Balance Sheet | |||||
Total Assets | 330.76B | 323.46B | 298.71B | 279.69B | 265.51B |
Cash, Cash Equivalents and Short-Term Investments | 27.45B | 22.74B | 29.65B | 34.66B | 32.38B |
Total Debt | 40.47B | 40.98B | 27.29B | 22.71B | 22.67B |
Total Liabilities | 94.58B | 92.56B | 77.19B | 71.68B | 64.95B |
Stockholders Equity | 233.29B | 227.47B | 218.42B | 205.91B | 198.83B |
Cash Flow | |||||
Free Cash Flow | 43.01B | 12.70B | 15.05B | 29.10B | 30.40B |
Operating Cash Flow | 59.18B | 33.70B | 35.23B | 41.95B | 39.94B |
Investing Cash Flow | -17.61B | -18.74B | -19.64B | -12.39B | -12.85B |
Financing Cash Flow | -35.65B | -22.10B | -25.03B | -27.87B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | €719.34B | 15.93 | 20.91% | 3.39% | 10.88% | 14.80% | |
74 Outperform | $748.43B | 15.51 | 6.04% | 3.93% | 3.71% | -19.97% | |
71 Outperform | $645.00B | 17.58 | 5.90% | 1.82% | 5.93% | 82.41% | |
66 Neutral | $1.12T | 44.46 | 1.29% | 4.06% | -6.66% | -78.39% | |
55 Neutral | $540.86B | 35.51 | 2.06% | 3.23% | 0.55% | -69.21% | |
54 Neutral | $654.98B | 67.60 | 0.92% | 2.25% | 0.98% | ― | |
44 Neutral | AU$1.47B | -5.90 | -41.17% | 4.21% | -3.35% | -41.14% |
Nissan Chemical Corporation has repurchased 440,000 of its own common shares on the Tokyo Stock Exchange, amounting to a total cost of 2,022,443,700 yen, as part of its ongoing share buyback program. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares by March 31, 2026, reflecting the company’s efforts to enhance shareholder value.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has announced the repurchase of 320,000 of its own shares on the Tokyo Stock Exchange, amounting to a total purchase cost of 1,351,956,000 yen. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares, reflecting a commitment to enhancing shareholder value and optimizing capital structure.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5800.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation has announced a decision by its Board of Directors to repurchase up to 2,500,000 of its own common shares, representing 1.84% of the total shares outstanding, excluding treasury shares. This move, with a total repurchase amount of up to 9 billion yen, aims to facilitate a flexible capital policy in response to the evolving business environment, potentially impacting the company’s market positioning and shareholder value.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.